Previous 10 | Next 10 |
Quotient Limited (QTNT) Q2 2021 Results Earnings Conference Call November 2, 2020, 08:00 AM ET Company Participants Peter Buhler - Chief Financial Officer Franz Walt - Chief Executive Officer Ed Farrell - Chief Operating Officer Conference Call Participants Josh Jennings - Cowen and Company S...
Quotient (QTNT): FQ2 GAAP EPS of -$0.18 beats by $0.16.Revenue of $16.07M (+104.7% Y/Y) beats by $8.19M.Press Release For further details see: Quotient EPS beats by $0.16, beats on revenue
FDA Emergency Use Authorization for the MosaiQ COVID-19 antibody test received FDA 510(k) clearance for Initial MosaiQ SDS microarray and MosaiQ instrument expected before the end of CY2020 European field trial for Expanded MosaiQ IH microarray progressing; on track for CE Mark su...
ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. The Strategy performed well in the third quarter in an en...
JERSEY, Channel Islands, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal second quarter ended September 30, 2020 will be released before market open on Monday, Nov 2, 2020. ...
Oxbridge Re Holdings (OXBR) +96%.Perceptron (PRCP) +67% on entering agreement to be acquired by Atlas Copco.Westwater Resources (WWR) +58%.Genfit SA (GNFT) +43% on NASH test deal with LabCorp.Lithium Americas (LAC) +29%.NexTier Oilfield Solutions (NEX) +23%.OpGen (OPGN)...
Quotient (QTNT) is ~13% higher on the heels of U.S. emergency use authorization for its COVID-19 antibody test, to detect antibodies in response to the SARS-CoV-2 virus using its MosaiQ blood testing microarray technology.A single MosaiQ testing instrument can process up t...
JERSEY, Channel Islands, Sept. 28, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), headquartered in Eysins, Switzerland, today announced that on September 25, 2020, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for Quotient's COVID-19 ...
Quotient (NASDAQ: QTNT ) slips 2% after-hours after pricing upsized $75M (from $60M) public offering. The Company is offering 17,647,059 ordinary shares at $4.25/share, a discounted price from yesterday's close of $4.82. More news on: Quotient Limited, Healthcare stocks new...
JERSEY, Channel Islands, Sept. 10, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT) (the Company), a commercial-stage diagnostics company, today announced the upsize and pricing of a $75 million underwritten public offering. The Company is offering 17,647,059 ordinary shares a...
News, Short Squeeze, Breakout and More Instantly...
Quotient Limited Company Name:
QTNT Stock Symbol:
NASDAQ Market:
3 Tips and Tricks For Managing Risk With Penny Stocks Risk management is an essential component of penny stock trading, as these stocks are often volatile and unpredictable. Proper risk management helps to minimize potential losses by setting strict limits on the amount of money that can be l...
3 Techniques for Day Trading Penny Stocks in 2023 Day trading penny stocks is a popular investment strategy due to its potential for high returns. The stock market can be volatile, and when done correctly, day trading penny stocks offers investors the opportunity to capitalize on quick fl...
JERSEY, Channel Islands, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (Nasdaq: QTNT) (the "Company") today announced that it has given formal notice to the Nasdaq Stock Market LLC ("Nasdaq") of its intention to voluntarily delist its ordinary shares from the Nasdaq Global Market. In order t...